Tenet Healthcare (THC) Tops Q1 EPS by 12c; Provides Q2, FY16 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Mizuho Securities Downgrades Tenet Healthcare (THC) to Neutral
May 4, 2016 7:23 AM EDTMizuho Securities downgraded Tenet Healthcare (NYSE: THC) from Outperform to Neutral with a price target of $33.00.
Analyst Sheryl Skolnick commented, "While we applaud the transformation of THC from an inpatient focused, singlenote play to a better-positioned, more diversified health care provider, we... More
